Prevalência do anti-HCV em pacientes soropositivos para o HIV

Carvalho, Flávia Helena Pontes de; Silva, Andréa Nazaré Monteiro Rangel da; Melo, Heloísa Ramos de Lacerda; Coêlho, Maria Rosângela Cunha Duarte.
Rev. para. med ; 20(3): 11-13, jul.-set. 2006. tab
Artigo em Português | LILACS | ID: lil-473902

Documentos relacionados

  1. High false discovery rate of the Architect anti-HCV screening test in blood donors in Uganda and evaluation of an algorithm for confirmatory testing.
  2. Community-based screening by Anti-HCV reflex HCV Ag test and accessible post-screening care toward elimination of hepatitis C in two hyperendemic townships.
  3. Prevalence of positivity to antibodies to hepatitis C virus among volunteer blood donors in China: a meta-analysis.
  4. Hepatitis C virus: Testing rate and attrition at linkage to specialized care, Catalonia, Spain 2011-2016.
  5. Identification of two novel anti-HCV E2 412-423 epitope antibodies by screening a Chinese-specific phage library.
  6. Hepatitis C Virus Vaccine Development: A Step Forward.
  7. Implementing community-based Dried Blood Spot (DBS) testing for HIV and hepatitis C: a qualitative analysis of key facilitators and ongoing challenges.
  8. Neutralizing antibodies evolve to exploit vulnerable sites in the HCV envelope glycoprotein E2 and mediate spontaneous clearance of infection.
  9. Seroprevalence rates of hepatitis C virus (HCV) antibody and hepatitis B virus surface antigen (HBsAG) in blood donors in a Southwestern Nigerian city.
  10. A territory-wide opportunistic, hospital-based HCV screening in the general population from northern Italy: The 1969-1989 birth-cohort.